![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/395 | (2006.01) |
A61P 35/04 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61K 31/395 | (2006.01) | ||
A61K 31/337 | (2006.01) | ||
A61K 47/68 | (2017.01) | ||
A61K 39/00 | (2006.01) | ||
C07K 16/32 | (2006.01) |
(11) | Number of the document | 3302551 |
(13) | Kind of document | T |
(96) | European patent application number | 16730123.3 |
Date of filing the European patent application | 2016-05-27 | |
(97) | Date of publication of the European application | 2018-04-11 |
(45) | Date of publication and mention of the grant of the patent | 2024-06-26 |
(46) | Date of publication of the claims translation | 2024-09-10 |
(86) | Number | PCT/US2016/034835 |
Date | 2016-05-27 |
(87) | Number | WO 2016/196373 |
Date | 2016-12-08 |
(30) | Number | Date | Country code |
201562168809 P | 2015-05-30 | US |
(72) |
GUARDINO, Alice, Elizabeth , US
SAMANT, Meghna , US
STRASAK, Alexander , US
SMITT, Melanie , US
PATRE, Monika , US
|
(73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Anksčiau negydyto metastazavusio HER2 teigiamo krūties vėžio gydymo būdai |
METHODS OF TREATING HER2-POSITIVE PREVIOUSLY UNTREATED METASTATIC BREAST CANCER |
Payment date | Validity (years) | Amount | |
2025-04-23 | 10 | 231.00 EUR |
2026-05-27 |